ClinicalTrials.govpublic full text
Hämeenlinna Metabolic Syndrome Research Program: Surrogate Indicators for Atherosclerosis
metabolic syndrome, coronary heart disease, erectile dysfunction, arterial elasticity, oxidized low density lipoprotein, cardiovascular diseases, risk assessment, endothelial dysfunction, diabetes mellitus, surrogate markers, risk factors, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 901335
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.